Media OutReach
IVD Medical Holding Limited (01931.HK): Officially launched the application for the US stablecoin license and accelerated the landing of the IVDNewCo Exchange ecosystem
In the wave of deep integration of global digital finance and medical innovation, IVD Medical Holding Limited(01931.HK) took the lead in building the “NewCo+RWA” Web3 exchange ecosystem (IVDNewCo Exchange) with the construction of medical innovative drugs high-tech assets as the core and the supporting stablecoin “IVDDollar” (IVDD) plan as the core strategy, leading the digital revolution of global medical innovation assets.
On July 20, 2025, the Board of Directors is pleased to announce that the US subsidiary carrying the Group’s aforementioned core strategic mission has landed, and the IVDNewCo Exchange ecosystem has officially landed on the international financial stage. The company released the latest announcement today, officially announcing two milestones: the US wholly-owned subsidiary IVD GROUP INC. has completed registration, and the Group has officially started the process of submitting a stablecoin license application to the US regulator through the subsidiary; at the same time, the Web3 exchange ecosystem with medical innovative drug NewCo assets as the core – IVDNewCo Exchange and its supporting stablecoin IVDD have entered a substantive stage.
This strategic move not only marks the Group’s leading position in the field of compliant digital finance for medical innovative drugs, but also heralds a revolutionary breakthrough in the global medical asset liquidity and value conversion model.
1. Strategic opportunities under global regulatory resonance
On July 18, 2025, local time, US President Trump signed the “Guidance and Establishment of the United States Stablecoin National Innovation Act” (hereinafter referred to as the “Genius Act”) at the White House, establishing the legal status of stablecoins as “digital dollars”. The implementation of this bill, together with the Stablecoin Ordinance of the Hong Kong Special Administrative Region, which will take effect on August 1, forms a regulatory synergy between the East and the West, and jointly builds the compliance cornerstone of the global stablecoin market.
The report of the China Banking Research Institute pointed out that currently 99% of the world’s stablecoins are anchored to US dollar assets, and US Treasury bonds have become the core choice of stablecoin reserve assets due to their low risk and high liquidity. In this context, the Group proactively laid out the application for the US stablecoin license, and on July 20 officially announced that the US subsidiary had initiated the process of submitting application materials to regulatory agencies such as the US SEC and CFTC, becoming one of the very few listed companies in the Hong Kong stock market that has completed the “Hong Kong + US” dual hub compliance architecture layout.
The strategic layout of the Group is deeply in line with the global regulatory trend. By establishing the US subsidiary IVD GROUP INC., we not only meet the strict requirements of the “Genius Act” for 100% reserve asset coverage and independent auditing of stablecoin issuers, but also rely on the sandbox mechanism of the Hong Kong “Stablecoin Ordinance” to build a cross-regional regulatory endorsement system. This dual hub model provides the IVDNewCo Exchange ecosystem with globally rare compliant liquidity support, enabling the Group to establish a first-mover advantage in the “Hong Kong Stock Stablecoin Concept Sector”.
2. Technological Innovation: “NewCo+RWA+Stablecoin” Reconstructs the Value Chain of Medical Innovative Drug Assets
The core breakthrough of the IVDNewCo Exchange ecosystem lies in the deep integration of Web3 technology and medical innovative drug assets. Relying on the commercial network covering 1,674 tertiary hospitals in China and the ability to acquire high-quality NewCo assets around the world, the Group has created the world’s first RWA (real world asset) tokenization platform focusing on medical innovative drugs. The platform achieves the following innovations through blockchain technology:
1). Asset tokenization: converting innovative drug assets such as ADC drugs, bi-antibody therapy, and cell gene therapy in the clinical stage into tradable and divisible digital certificates to break through the liquidity bottleneck of traditional medical assets;
2). Compliance financial infrastructure: establish an underlying architecture to support the issuance, trading and settlement of IVDD stablecoins, ensuring that each $1 stablecoin corresponds to ultra-short-term U.S. Treasury bonds and other low-risk assets, meeting the U.S. SEC’s “1:1 redeemable” requirements;
3). Coin-stock linkage mechanism: coordinate with Nasdaq’s dual primary listing plan to explore the compound value creation model of “digital assets + traditional equity” to attract two-way inflows of traditional medical capital and crypto-native funds.
The implementation of this technical architecture has been strongly supported by industry data. Public information shows that the current global innovative drug market has exceeded US$1.2 trillion, and China accounts for 6% of the market with a scale of RMB 450 billion, with an annual compound growth rate of 20.3%. Through the RWA platform, the Group expects to significantly improve the financing efficiency of innovative drug assets, while lowering the entry threshold for investors, allowing small and medium-sized investors around the world to participate in the medical innovation field that was originally limited to institutional investment.
3. Ecological synergy: creating a new paradigm for medical finance
The Group’s strategic advancement has always followed the three-dimensional path of “regulatory compliance-technological innovation-ecological synergy”. In the United States, IVD GROUP INC.’s license application strictly follows the requirements of the Genius Act for reserve asset transparency, anti-money laundering (AML) and network security. Its technical system has passed a third-party security audit to ensure that smart contracts are free of loopholes; in Hong Kong, the Group will actively promote participation in the HKMA’s stablecoin sandbox program to test reserve asset management and cross-border payment scenarios, laying the foundation for license application.
More importantly, the implementation of the IVDNewCo Exchange ecosystem is reshaping the value chain of innovative medical drugs. Under the traditional model, the research and development of innovative drugs requires a cycle of up to 10 years, and 80% of the funds are concentrated in the clinical stage. Through the RWA platform, the Group can monetize clinical-stage assets in advance, provide pharmaceutical companies with low-cost financing channels, and provide investors with dynamic returns linked to the progress of drug development. For example, an ADC drug in Phase II clinical trials can attract global capital participation through tokenization, and its development progress data will be uploaded to the chain in real time to ensure that investors’ rights and interests are transparent and traceable.
4. Industry Impact and Future Outlook
The Group’s strategic initiatives have attracted widespread attention from the capital market and the industry. After the announcement on the 17th, IVD Medical’s share price opened sharply higher on the 18th, closing at HK$2.95, up 20.41% throughout the day, with a turnover exceeding HK$9.4886 million and a market value of HK$4.783 billion. Behind the market data is investors’ strong confidence in the cross-border integration of “NewCo+RWA+stablecoin”.
Looking ahead, the Group will continue to deepen the three strategic directions of compliance expansion, technology deepening and ecological integration. Against the backdrop of the global low interest rate environment and the surge in demand for medical innovation, it will use Web3 technology as a bridge to connect traditional medical capital and digital financial innovation. We firmly believe that through compliance layout and technological innovation, the IVDNewCo Exchange ecosystem will become a value amplifier for global innovative medical drug assets, creating a win-win situation for patients, pharmaceutical companies and investors.
Hashtag: #IVDMedicalHoldingLimited
The issuer is solely responsible for the content of this announcement.
Media OutReach
Columbia Asia Hospital Tebrau Wins ESG Champion Award For Sustainable Healthcare At Sustainability & CSR Malaysia Awards 2026
The Sustainability & CSR Malaysia Awards 2026, supported by the Ministry of Women, Family and Community Development, is one of Malaysia’s recognized platforms for celebrating organizations that demonstrate excellence in sustainability, corporate social responsibility (CSR), and Environmental, Social and Governance (ESG) practices. The award ceremony was officiated in Kuala Lumpur by YB Lim Hui Ying, Deputy Minister of Women, Family and Community Development, underscoring the national significance of advancing sustainable and socially responsible business practices in Malaysia.
Columbia Asia Hospital Tebrau received the award for integrating sustainability into healthcare delivery while improving health outcomes for the Johor community. The national award recognizes the hospital’s leadership in environmental sustainability, responsible governance, community health programs and sustainable healthcare delivery in Malaysia.
The award recognizes Columbia Asia Hospital Tebrau’s unwavering commitment to integrating sustainability into healthcare delivery while creating meaningful and lasting value for the communities it serves. It reflects the hospital’s dedication to responsible governance, environmental stewardship and community well-being.
Over the years, Columbia Asia Hospital Tebrau has embraced its mission of “Caring Beyond Boundaries” by extending quality healthcare beyond the hospital walls through impactful Corporate Social Responsibility (CSR) initiatives, preventive health education, free health screening programmes and strategic community partnerships. These initiatives have empowered thousands of individuals to take charge of their health while improving access to quality healthcare in Johor Bahru and even across Johor.
Beyond its community outreach, Columbia Asia Hospital Tebrau has embedded green initiatives into its daily operations through energy-efficient practices, responsible waste management, recycling initiatives, digitalisation and paperless workflows to minimise its environmental footprint. These efforts reflect the hospital’s commitment to delivering high-quality, patient-centred care while fostering long-term healthcare sustainability.
Receiving the Company of the Year – ESG Champion for Health, Wellness and Sustainability Award reflects the hospital’s holistic approach to sustainability; balancing quality healthcare, environmental responsibility and good governance to create a healthier and more sustainable future.
“This recognition is a proud milestone for our entire team and reinforces our commitment to delivering not only quality healthcare but also lasting value to our communities,” said Dr. James Chong, Chief Executive Officer of Columbia Asia Hospital Tebrau. “Healthcare organizations have a responsibility beyond treating illness. We believe sustainable healthcare means improving community health, reducing environmental impact and strengthening responsible clinical governance. This recognition reflects how Columbia Asia Hospital Tebrau integrates these commitments into everyday patient care.”
The hospital attributes this achievement to the unwavering dedication of its doctors, nurses, allied health professionals and support staff, whose passion and commitment have enabled Columbia Asia Hospital Tebrau to consistently deliver compassionate, patient-centred care while championing ESG and sustainability initiatives.
Looking ahead, Columbia Asia Hospital Tebrau remains committed to strengthening community partnerships, embracing innovative healthcare solutions and further advancing sustainable healthcare through responsible environmental stewardship and digital transformation.
Hashtag: #ColumbiaAsiaHospitalTebrau #RightHereForYou #HealthcareExcellence #TeamTebrau #CommunityCare #HospitalCommunications #AwardWinningTeam #CSRMalaysiaAward #CSR #Sustainability #ESG
https://www.columbiaasia.com/malaysia/hospitals/tebrau/
https://www.linkedin.com/company/columbia-asia-malaysia/
https://x.com/columbiaasia?s=11
https://www.facebook.com/ColumbiaAsiaHospitalTebrau
https://www.instagram.com/columbiaasia/
Tiktok : 
https://www.tiktok.com/@columbiaasiamalaysia?_r=1&_t=ZS-98n3fNa4Eab
The issuer is solely responsible for the content of this announcement.
About Columbia Asia
For 30 years, Columbia Asia Group of hospitals has been at the forefront of quality healthcare in the private healthcare industry. Established in 1996, it has evolved from its first hospital in Shah Alam to its latest in Penang, to date. As an international healthcare provider, its services span across 19 hospitals in the region; 13 in Malaysia, five in Indonesia, and one in Vietnam. Through the years, the company strategy has always been about making private healthcare accessible to all, hence its hospitals are strategically located in densely populated areas. Under the umbrella of private healthcare company, Asia OneHealthcare, the Columbia Asia group has expanded its reach to bring effective healthcare, closer to home.
Through the years, Columbia Asia’s emphasis has consistently been about early detection of diseases. This is achieved through advanced diagnostic technology that enables greater precision and supports minimally invasive procedures. To fulfil the typical healthcare needs of communities, Columbia Asia offers core disciplines such as obstetrics & gynecology, pediatrics, and general surgery. Today, it also provides tertiary healthcare addressing more complex fields of medicine such as neurosurgery, cardiac disease treatments, and integrated cancer care.
As it approaches a new decade, Columbia Asia continues to expand; adopting advanced technology to meet the ever-increasing needs of today’s discerning customers.
Upholding strict clinical governance and medical ethics, Columbia Asia is committed to deliver excellent patient outcomes in a safe and trusted environment.
Columbia Asia. Right Here For You.
About Asia OneHealthcare
Asia OneHealthcare (A1H) unites 32 hospitals across Malaysia, Indonesia, and Vietnam into one connected healthcare network with a shared purpose. Built on Columbia Asia’s strong community focused hospitals network and complemented by advanced tertiary and super-specialty centres, A1H is dedicated to caring for people during some of the most important moments of their lives — when they are most in need of trusted medical care.
Our network includes leading institutions such as Subang Jaya Medical Centre (SJMC) and super-specialty hospitals including ALTY Orthopaedic Hospital, Beacon Hospital, Cardiac Vascular Sentral Kuala Lumpur (CVSKL), Hospital Picaso, and Northern Heart Hospital Penang. Together, they provide access to advanced clinical expertise, specialised treatments, and modern medical technology, delivering the best care possible.
With over 4,000 beds across the region, A1H delivers seamless, coordinated care — from initial diagnosis and treatment to complex, life-saving procedures. Guided by our promise, Right Here For You, A1H is committed to standing alongside patients, families, and communities with compassionate, high-quality care when it matters most.
Media OutReach
Orbis Future Vision Leaders 2025/26 Mobilizes 330+ Hong Kong Tertiary Students to Serve Over 2,200 Community Beneficiaries
The campaign spans three core tracks:
- Heal the Future: Infusing medical blindness prevention with psychological empathy and public health outreach.
- Educator 2.0: Deep-diving into campus eye care education and fostering inclusive values in schools.
- Visionary Start-up: Exploring social enterprise models to deliver sustainable accessibility solutions.
Cross-Disciplinary Mobilization Across 10 Hong Kong Universities
Mary Lau, Executive Director of Orbis Hong Kong, praised the student cohorts for independently connecting with over 25 community partners. Through these grassroots collaborations, student teams designed and executed a wide range of interactive eye advocacy initiatives, including vision screenings, clinical escape rooms, AR eye disease simulations, and braille decoding workshops, directly serving more than 2,200 citizens.
The initiative rallied students from 10 major tertiary institutions across Hong Kong (listed in no particular order):
- The University of Hong Kong (HKU)
- The Chinese University of Hong Kong (CUHK)
- The Hong Kong University of Science and Technology (HKUST)
- The Hong Kong Polytechnic University (PolyU)
- Hong Kong Metropolitan University (HKMU)
- Lingnan University (LU)
- The Education University of Hong Kong (EdUHK)
- Hong Kong Baptist University (HKBU)
- The Hang Seng University of Hong Kong (HSUHK)
- City University of Hong Kong (CityU)
CEO Mentorship & Distinguished Judging Panel
To bolster the commercial viability and social impact of the Visionary Start-up track, Orbis engaged prominent corporate mentors to guide youth teams in market strategy and operational planning.
Participating Mentor Companies (in no particular order): Climate Incubator, Education for Good, HK Decoman Technology, Pet Space Group Limited, SOFE COFFEE, and V Cycle.
Grand Final Judging Panel:
- Ms. Mary Lau (Executive Director, Orbis Hong Kong)
- Dr. Vincent Lee Yau-wing (Orbis Volunteer Ophthalmologist & Specialist in Ophthalmology)
- Ms. Sharon Wang (Investment Manager, Beyond Ventures)
- Mr. Francis Ngai (Founder & CEO, Social Ventures Hong Kong)
- Mrs. Julie Ma (Principal, St. Stephen’s College)
Official Launch of the 2026/27 Campaign Cycle
The event concluded with a formal lighting ceremony led by the overall track champions, Orbis Executive Director Mary Lau, and academic representatives from participating universities. The ceremonial lighting of the stage centerpiece marked the conclusion of this cycle and signaled the official launch of the 2026/27 Future Vision Leaders Campaign.
Schools, academic faculties, and community institutions interested in co-curricular partnerships for the upcoming cycle can submit inquiries to [email protected]
Full List of Award Winners: Orbis Future Vision Leaders 2025/26
Overall Track Champions
Heal the Future Overall Champion: The University of Hong Kong
- Project: Created the AEyeChatbot and AEyeScreen Helper web tools via AI/AR to connect with 1,000+ users and boost literacy.
- Team Members: Chan Tsz Ching, Angelina Cheng, Lee Po Wa, Ng Man Lok, Ho Chak Fung.
Educator 2.0 Overall Champion: The Chinese University of Hong Kong
- Project: School workshops combining visual simulation and tactile painting to foster inclusive values among children.
- Team Members: Siu Yan Tung Valerie, Wu Pui Yi, Cheung Hei Long Chloe, Chui Wui
Visionary Start-up Overall Champion: The University of Hong Kong
- Project: Offline digital twin navigation system assisting visually impaired elderly residents in GPS dead zones such as MTR stations.
- Team Members: Sirot Inthasorn, Napat Arjananont, Virakarn Boonfahpratan, Nutnornont Chamadol, Apiwit Triwatana.
Category Winners
1. Heal the Future Track
Vision for theCommunity Award: Hong Kong Metropolitan University (Ng Tim Tim, Wu Nai Wan Rebecca, KeithYeung, Kung Huen Nok) — Launched a Braille workshop, AR senior simulations, and a nursing escape room to drive community blind awareness.
Medical In SightAward: The Hong Kong Polytechnic University (Wong Pak Hei, Choy Yan Lam, Wong Mei Sze, Chiu Sze Ching, Wong Hiu Lam) — Delivered bilingual workshops and tailored eye screenings that evaluated over 110 ethnic minority seniors and empowered their caregivers.
Innovative Perspectivesin Technology Award: The University of Hong Kong (Chan Tsz Ching, Angelina Cheng, Lee Po Wa,Ng Man Lok, Ho Chak Fung) — Created the AEyeChatbot and AEyeScreen Helper web tools via AI/AR to connect with 1,000+ users and boost literacy.
Inclusivity for the VisuallyImpaired Community Award: The University of Hong Kong (Ng Tsun Hin, Chan Chun Yin, Cherry Lam,Winston Lam, Lam Cheung Yeung) — Hosted a blindfolded running workshop alongside a visually impaired athlete to build critical empathy with medical students.
2. Educator 2.0 Track
Color Adventures Award: The Hong Kong Polytechnic University (Tsang Pok Hei, Wu Hoi Shan, Tong Chi Kit, Ng Yu Hei) — Deployed an interactive Inside Out themed workshop featuring Stroop tests, paper folding, and drawing sessions to teach primary school students about eye structures, color blindness, and the connection between emotions and colors.
Eye Health Mission Award: Lingnan University / The Education University of Hong Kong (Cheung Ka Wun, Chan Yat Yi, Chan Wing Sze, Gu Shu Ya) — Organised the zero-budget ‘Sight-athlon’ carnival for primary students using AR eye simulations and Braille decoding.
The Unseen World Award: Lingnan University / The Hang Seng University of Hong Kong / Hong Kong Baptist University (Pang Yu Fei, Lo Hoi Chiu, Fan Man Kit) — Implemented a low-cost simulation workshop using DIY glasses to let school children experience glaucoma and color blindness.
Defeating VisionMonsters Award: The Chinese University of Hong Kong (Siu Yan Tung Valerie, Wu Pui Yi, Cheung HeiLong Chloe, Chui Wui) — Managed a color-blindness simulation glasses painting workshop to foster youth STEAM literacy and active prevention awareness.
3. Visionary Start-up Track
Joyful Journeys toWellness Award: The Chinese University of Hong Kong (Chan Ching Tung, Chan Hau Ying, Deng Yu Hing, Au Wing Sze) — Developed ZIP, a gamified walking app utilizing commission-based models to promote lowcarbon urban wellness.
Tech Solutions forChallenges Award: The University of Hong Kong (Sirot Inthasorn, Napat Arjananont, Virakarn Boonfahpratan, Nutnornont Chamadol, Apiwit Triwatana) —Developed GUIDO, an AI-powered 3D SLAM navigation device mitigating urban transit barriers via a Device-as-a-Service framework.
Co-Creating Community Award: The Hong Kong Polytechnic University / The Hong Kong University of Science and Technology (Yue Yee Ting, Ng Chiu Yee, Chan Chin Yik, Ho Lok Hin) — Formed an ecosystem connector program that bridges schools and NGOs while empowering visually impaired individuals as instructors.
Visual Arts Unleashed Award: Hong Kong Metropolitan University (Fung Ying Ching, Chan Yui Man, Wong Tsz Yi,Li Tsam Yu) — Established a tactile 3D art ecosystem allowing visually impaired individuals to independently create and experience gallery exhibits.
Hashtag: #OrbisHongKong
The issuer is solely responsible for the content of this announcement.
Media OutReach
AsianPLAS 2026 Connects Global Buyers with Plastics & Rubber Suppliers Through an Extended Online Exhibition
Organized jointly by AsianNet and the B2B marketplace TradeAsia, AsianPLAS 2026 provides participating companies with extended international exposure while enabling buyers to discover products, review supplier information, and submit sourcing inquiries online. Through TradeAsia’s B2B platform and digital matchmaking resources, the exhibition facilitates connections between global buyers and plastics and rubber suppliers, creating additional opportunities for international sourcing and cross-border business cooperation.
Expanding International Sourcing Opportunities Through Global Industry Exposure
To increase global visibility and sourcing opportunities, AsianPLAS 2026 aligns its exhibition period with several major international plastics and rubber industry events, including Expo Plast Peru, Taipei International Plastics and Rubber Industry Show, West Africa Plastprintpack, Fakuma, PLAST IMAGEN MEXICO, and IPF Japan. By running alongside major international industry exhibitions, AsianPLAS 2026 provides additional opportunities for participating suppliers to reach international buyers and expand their exposure across global markets.
Through AsianPLAS 2026, buyers can review supplier information, browse product catalogs, and directly contact exhibitors for sourcing inquiries. The platform gives international buyers convenient access to plastics and rubber manufacturers and suppliers across a wide range of materials, machinery, products, and related industry applications, while helping participating companies strengthen their international visibility and explore new business opportunities.
Comprehensive Product Categories and Industry Suppliers Across the Plastics & Rubber Sector
The exhibition brings together suppliers and manufacturers from across Asia’s plastics and rubber industry. International buyers can explore products and sourcing opportunities presented by companies including ELASTIN INTERNATIONAL, YI CHI HSIUNG, SHANG-YUH MACHINE, LIO CHENG KUNG, UNILONGENTERPRISECO and KAIPHONE TECHNOLOGY.
These exhibitors represent a diverse range of products and applications across the plastics and rubber supply chain, including plastic and rubber materials, processing machinery, plastic and rubber products, packaging and containers, polymers and resins, adhesives and sealants, coatings, chemical additives, and related industrial equipment.
Supporting Global B2B Trade Through Digital Sourcing Solutions
Powered by TradeAsia’s B2B platform, AsianPLAS 2026 provides exhibitors with online product showcases, supplier profiles, and digital e-catalogs designed to increase international exposure and sourcing opportunities.
International buyers can browse products and communicate with suppliers online regardless of location or time zone, making it easier to compare products, review supplier capabilities, and submit inquiries efficiently. The exhibition’s extended online format also enables participating companies to maintain continuous visibility throughout the more than four-month exhibition period.
By integrating online sourcing, digital promotion, and buyer-supplier matchmaking services, AsianPLAS 2026 creates an efficient digital environment for global B2B trade and international procurement across the plastics and rubber industry.
Start Sourcing Now
Explore suppliers, discover products, and connect directly with exhibitors through the official AsianPLAS 2026 online exhibition platform:
https://www.etradeasia.com/online-show/47/Asian-Plastics-Rubber-Industry-Online-Exhibition-2026.html
Hashtag: #TradeAsia
The issuer is solely responsible for the content of this announcement.
About TradeAsia
TradeAsia, available at 
www.e-tradeasia.com, is a B2B digital marketplace connecting international buyers with suppliers across global markets. The platform brings together a broad network of buyers and suppliers with an extensive product database, helping procurement professionals discover products, identify potential suppliers, and initiate business inquiries online.
In addition to its digital platform, TradeAsia works with international trade organizations and industry exhibition organizers to connect online marketing resources with global industry events. By combining digital product exposure, international buyer reach, and industry marketing resources, TradeAsia helps suppliers strengthen their international visibility and create new opportunities for cross-border business development.
